JOP20220090A1 - عملية كيميائية ضوئية لإنتاج (4r، 4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد - Google Patents

عملية كيميائية ضوئية لإنتاج (4r، 4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد

Info

Publication number
JOP20220090A1
JOP20220090A1 JOP/2022/0090A JOP20220090A JOP20220090A1 JO P20220090 A1 JOP20220090 A1 JO P20220090A1 JO P20220090 A JOP20220090 A JO P20220090A JO P20220090 A1 JOP20220090 A1 JO P20220090A1
Authority
JO
Jordan
Prior art keywords
naphthyridin
carboxamide
methoxyphenyl
dihydro
ethoxy
Prior art date
Application number
JOP/2022/0090A
Other languages
English (en)
Inventor
Lovis Kai
Platzek Johannes
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of JOP20220090A1 publication Critical patent/JOP20220090A1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بعمليات لإنتاج (4R، 4S)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد راسيمي بالصيغة (I) من البد (Ia) أو (Ib) ؛ عملية لإنتاج (4S)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد بالصيغة (Ia) ؛ عملية لإنتاج (4R، 4S)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد راسيمي بالصيغة (I) من بيريدين بالصيغة (II). وتشترك مواضيع الاختراع في تشعيع المركبات بالصيغ (Ia) و (Ib) و / أو (II) باستخدام الضوء في مذيب أو خليط مذيب مناسب ، بوجود قاعدة. وتمثل المركبات بالصيغ (Ia) و (Ib) و / أو (II) منتجات وسيطة، منتجات ثانوية أو مركبات مستهدفة في تصنيع فينيرينون (المركب وفقًا للصيغة (Ia))
JOP/2022/0090A 2019-10-17 2020-10-12 عملية كيميائية ضوئية لإنتاج (4r، 4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد JOP20220090A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19203824 2019-10-17
PCT/EP2020/078614 WO2021074079A1 (de) 2019-10-17 2020-10-12 Photochemisches verfahren zur herstellung von (4r, 4s)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carbox-amid

Publications (1)

Publication Number Publication Date
JOP20220090A1 true JOP20220090A1 (ar) 2023-01-30

Family

ID=68281312

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2022/0090A JOP20220090A1 (ar) 2019-10-17 2020-10-12 عملية كيميائية ضوئية لإنتاج (4r، 4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد

Country Status (14)

Country Link
US (1) US20240150357A1 (ar)
EP (1) EP4045502A1 (ar)
JP (1) JP2022553224A (ar)
KR (1) KR20220084104A (ar)
AU (1) AU2020365351A1 (ar)
BR (1) BR112022005899A2 (ar)
CA (1) CA3158167A1 (ar)
CO (1) CO2022004463A2 (ar)
CR (1) CR20220158A (ar)
IL (1) IL292191A (ar)
JO (1) JOP20220090A1 (ar)
MX (1) MX2022004466A (ar)
PE (1) PE20221420A1 (ar)
WO (1) WO2021074079A1 (ar)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524812A (zh) * 2022-03-18 2022-05-24 湖南凯铂生物药业有限公司 1,4-二氢-1,6-萘啶化合物的晶型制备以及合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007009494A1 (de) * 2007-02-27 2008-08-28 Bayer Healthcare Ag Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
HUE051350T2 (hu) * 2014-08-01 2021-03-01 Bayer Pharma AG Eljárás (4S)-4-(4-ciano-2-metoxifenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftridin-3-karboxamid elõállítására és tisztítására gyógyászati hatóanyagként való alkalmazása céljából
AU2016311135C1 (en) * 2015-08-21 2022-10-13 Bayer Pharma Aktiengesellschaft Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and recovery of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide by electrochemical methods

Also Published As

Publication number Publication date
KR20220084104A (ko) 2022-06-21
PE20221420A1 (es) 2022-09-20
CO2022004463A2 (es) 2022-04-29
CN114555598A (zh) 2022-05-27
US20240150357A1 (en) 2024-05-09
CA3158167A1 (en) 2021-04-22
CR20220158A (es) 2022-06-15
WO2021074079A1 (de) 2021-04-22
AU2020365351A1 (en) 2022-05-12
MX2022004466A (es) 2022-05-03
BR112022005899A2 (pt) 2022-06-28
JP2022553224A (ja) 2022-12-22
EP4045502A1 (de) 2022-08-24
IL292191A (en) 2022-06-01

Similar Documents

Publication Publication Date Title
TN2018000319A1 (en) Macrocyclic mcl1 inhibitors for treating cancer
PH12016501440A1 (en) Novel heterocyclic compounds
HK1147490A1 (en) Condensed aminodihydrothiazine derivative
MX2014005870A (es) Proceso para preparar compuestos de 1h -pirazol - 5 - carboxilato n - sustituidos y derivados de los mismos.
JP2005534713A (ja) ジヒドロピラゾロピリジン化合物
EA201070864A1 (ru) Новые гетероциклические соединения
PE20221322A1 (es) Procedimiento para preparar (4s)-4-(4-ciano-2-metoxi-fenil)-5-etoxi-2,8-dimetil-1,4-dihidro-1,6- naftiridin-3-carboxilato de 2-cianoetilo mediante separacion de racematos utilizando esteres diastereomericos de acido tartarico
ATE381559T1 (de) Adamantan- und azabicyclooctan- und - nonanderivate, verfahren zu deren herstellung und deren verwendung als dpp-iv-inhibitoren
UY28333A1 (es) Inhibidores de caspasa y sus usos.
AR057063A1 (es) Moduladores de tienopirimidina y tienopiridina quinasa y composicion farmaceutica
PL177155B1 (pl) Pochodne 7-izoindolinylo-chinolonu i-naftyrydonu i sposób ich wytwarzania
MY163164A (en) Ethynyl derivatives as positive allosteric modulators of the mglur5
MX2018014164A (es) Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico.
AU2019267846A1 (en) Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
MA40480B1 (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
JOP20220090A1 (ar) عملية كيميائية ضوئية لإنتاج (4r، 4s)-4-(4-سيانو-2-مثوكسي فنيل)-5-إثوكسي-2، 8-ثنائي مثيل-1، 4-ثنائي هيدرو-1، 6-نفثيريدين-3-كربوكساميد
MX2020012691A (es) Proceso para la sintesis del acido (s)-3-amino-4-(difluorometileni l)ciclopent-1-eno-1-carboxilico.
CR20220161A (es) Procedimiento para preparar ésteres aciloximetílicos del ácido (4s)–(4–ciano–2–metoxifenil)–5–etoxi–2,8–dimetil–1,4–dihidro–1,6–naftiridin–3–carboxílico
Feng et al. Highly regioselective synthesis of 3-alkenyl-oxindole ring-fused 3, 3′-disubstituted oxindoles via direct gamma-substitution of Morita–Baylis–Hillman carbonates of isatins with 3-substituted oxindoles
BR112022001922A2 (pt) Compostos de heteroarila de anel fundido como inibidores de ripk1
CN104710429B (zh) 手性螺环磷酸催化合成光学活性喹喔啉衍生物的方法
MX2021014319A (es) Metodo de sintesis del compuesto de furoimidazopiridina, forma de cristal del compuesto de furoimidazopiridina, y forma de cristal de la sal del mismo.
Iwanejko et al. Stereoselective preparation of chiral compounds in Mannich-type reactions of a bicyclic imine and phenols or indole
GB2583606A (en) Indoleamine 2,3-Dioxygenase inhibitors and use of same in medicine
MY192335A (en) Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane